IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q4 2017 Holdings

Filed 2018-02-14 | 14 holdings | $67.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corvus Pharmaceuticals Inc(CRVS)COM221015100$33.6M3,244,04649.9%
Akebia Therapeutics Inc(AKBA)COM00972D105$33.1M2,225,00049.1%
Inogen Inc(INGN)COM45780L104$422.7K3,549,3200.6%
Acceleron Pharma Inc(XLRN)COM00434H108$65.9K1,553,9370.1%
Dermira Inc(DERMEUR)COM24983L104$55.2K1,984,3640.1%
Merus N VCOMN5749R100$27.4K1,410,4170.0%
Nabriva Therapeutics PLCSHSG63637105$17.5K2,924,8220.0%
RA Pharmaceuticals IncCOM74933V108$17.3K2,031,5620.0%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$8.8K740,7400.0%
Invuity IncCOM NEW46187J205$8.5K1,363,8480.0%
Orthopediatrics Inc(KIDS)COM68752L100$7.3K379,0140.0%
Wright MED Group N VRIGHT 03/01/2019N96617126$7.0K$4,622,0320.0%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$5.2K223,3170.0%
Glaukos Corp(GKOS)COM377322102$4.0K156,4290.0%